Are you tired of boring dieting and gruesome workouts? Then, medical weight loss treatment can be a solution for you. But ...

It is the biggest shake-up of obesity treatment in NHS history, it has been claimed. From later this month, GPs will be able ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

It's been a tough year for Novo Nordisk, the Danish pharmaceutical company behind the GLP-1 drugs Ozempic and Wegovy.

The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off ...

Amber Salazar is the kind of idealist you just knew would end up running a store like Banned Wagon Books. She's a lifelong ...

It is now illegal to publish or threaten to publish real or AI-generated intimate images of a person without their consent. Tech sites and companies also must take down such images within 48 hours of ...

GT Biopharma, Inc. announced the successful completion of Cohort 1 in its Phase 1 trial for GTB-3650, a treatment for relapsed or refractory CD33 expressing hematologic malignancies. Following a ...

Get ready to relive the magic of the iconic 80s vampire flick that defined a generation! The Paradise Theatre of Paonia is thrilled to announce a special screening of The ...

Novo Nordisk CEO Lars Fruergaard Jørgensen will step down after eight years at the helm, as the Danish pharmaceutical giant battles intensifying competition in the global obesity drug market. The ...

The pharmaceutical giant Novo Nordisk announced on Friday, May 16, 2025, that CEO Lars Fruergaard Jørgensen is stepping down amid mounting challenges for the obesity drug maker. The sudden leadership ...

Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.